Stock Scorer

Globus Medical (GMED) · Insider trading

What Globus Medical's directors, officers and largest holders bought and sold themselves, from the Form 4 each of them files with the SEC within two business days of a trade. Open-market purchases and sales first: those are the trades somebody chose to make at the market price.

Bought, 12 months
$0
0 insiders, 0 trades
Sold, 12 months
$17.54M
7 insiders, 39% under a plan
Net, 12 months
−$17.54M
bought less sold
Latest filing
2026-09-16
filings read to 2026-10-19

Bought and sold at the market, by month

Two years. Purchases above the line, sales below, in dollars.

2024-11: $20.88M sold 2024-12: $217,500 sold 2025-01: $1.25M sold 2025-01 2025-02: $590,100 sold 2025-07 2025-09: $584,600 sold 2025-11: $5.75M sold 2025-12: $2.02M sold 2026-01: $565,553 sold 2026-01 2026-02: $2.77M sold 2026-06: $2.02M sold 2026-07 2026-08: $2.18M sold 2026-09: $2.24M sold
Bought Sold Largest month: $20.88M

Who traded, two years

InsiderBoughtSold TradesLast tradeHolds after
Scavilla Daniel TDirector, President, CEO – $15.85M 2 2024-11-21 0
Davidar David DDirector – $7.57M 6 2026-06-05 510,175
Zarrilli Stephen TDirector – $4.28M 2 2026-08-18 0
Huller KellyEVP, GC, Corporate Secretary – $4.06M 6 2026-02-25 0
Tobin James RDirector – $2.24M 1 2026-09-15 0
Kline KyleSenior Vice President, CFO – $2.03M 2 2026-01-08 0
Rhoads Ann DDirector – $1.99M 4 2025-11-10 15,384
Pfeil Keith WCOO, CFO – $1.25M 2 2025-01-10 1,666
Lemaitre DanDirector – $1.22M 2 2024-11-22 0
Norwalk Leslie VDirector – $557,600 2 2026-01-08 10,419

Open-market purchases and sales

Newest first. “Plan” marks a trade made under a 10b5-1 plan set up in advance.

DateInsiderTradeShares PriceValueHolds afterFiling
2026-09-15 Tobin James RDirector Sale 30,000 74.58 $2.24M 0 Form 4
2026-08-18 Zarrilli Stephen TDirector Sale 25,000 87.04 $2.18M 0 Form 4
2026-06-05 Davidar David DDirector Sale 25,000 80.76 $2.02M 510,175 Form 4
2026-02-25 Huller KellyEVP, GC, Corporate Secretary Saleplan 20,000 94.50 $1.89M 0 Form 4
2026-02-12 Huller KellyEVP, GC, Corporate Secretary Saleplan 10,000 87.67 $876,700 0 Form 4
2026-01-08 Norwalk Leslie VDirector Saleplan 2,000 101.10 $202,200 10,419 Form 4
2026-01-08 Kline KyleSenior Vice President, CFO Saleplan 3,594 101.10 $363,353 0 Form 4
2025-12-12 Norwalk Leslie VDirector Saleplan 4,000 88.85 $355,400 12,419 Form 4
2025-12-01 Kline KyleSenior Vice President, CFO Saleplan 18,542 90.00 $1.67M 0 Form 4
2025-11-25 Huller KellySVP, GC, Corporate Secretary Saleplan 7,500 90.00 $675,000 0 Form 4
2025-11-12 Davidar David DDirector Sale 25,000 86.00 $2.15M 516,275 Form 4
2025-11-11 Zarrilli Stephen TDirector Sale 25,000 84.29 $2.11M 0 Form 4
2025-11-10 Rhoads Ann DDirector Saleplan 2,000 85.00 $170,000 15,384 Form 4
2025-11-07 Rhoads Ann DDirector Saleplan 8,000 81.00 $648,000 17,384 Form 4
2025-09-15 Rhoads Ann DDirector Saleplan 10,000 58.46 $584,600 25,384 Form 4
2025-02-28 Rhoads Ann DDirector Saleplan 7,500 78.68 $590,100 35,384 Form 4
2025-01-10 Pfeil Keith WCOO, CFO Saleplan 12,501 88.17 $1.10M 1,666 Form 4
2025-01-10 Pfeil Keith WCOO, CFO Saleplan 1,666 89.17 $148,557 0 Form 4
2024-12-02 Huller KellySVP, GC, Corporate Secretary Saleplan 2,500 87.00 $217,500 0 Form 4
2024-11-22 Lemaitre DanDirector Sale 1,097 85.02 $93,267 0 Form 4
2024-11-22 Davidar David DDirector Saleplan 6,766 85.00 $575,110 516,275 Form 4
2024-11-22 Davidar David DDirector Saleplanindirect 6,746 85.00 $573,410 165,967 Form 4
2024-11-21 Scavilla Daniel TDirector, President, CEO Saleplan 130,000 85.00 $11.05M 0 Form 4
2024-11-21 Lemaitre DanDirector Sale 13,278 85.00 $1.13M 0 Form 4
2024-11-21 Davidar David DDirector Saleplan 13,234 85.00 $1.12M 523,041 Form 4
2024-11-21 Davidar David DDirector Saleplanindirect 13,254 85.00 $1.13M 172,713 Form 4
2024-11-06 Scavilla Daniel TDirector, President, CEO Saleplan 60,000 80.02 $4.80M 0 Form 4
2024-11-06 Huller KellySVP, GC, Corporate Secretary Saleplan 2,500 80.02 $200,050 2,500 Form 4
2024-11-06 Huller KellySVP, GC, Corporate Secretary Saleplan 2,500 82.00 $205,000 0 Form 4

Grants, exercises and other transactions

Pay, tax and paperwork rather than a choice to trade at the market price. Two years.

27 × option exercise2 × gift
Show them
DateInsiderWhatShares PriceHolds afterFiling
2026-09-15 Tobin James RDirector Option exercise M +15,000 53.75 15,000 Form 4
2026-09-15 Tobin James RDirector Option exercise M +15,000 63.68 30,000 Form 4
2026-08-18 Zarrilli Stephen TDirector Option exercise M +25,000 53.27 25,000 Form 4
2026-07-27 Davidar David DDirector Gift G −2,500 – 507,675 Form 4
2026-06-05 Davidar David DDirector Option exercise M +25,000 26.27 535,175 Form 4
2026-06-04 Rhoads Ann DDirector Option exercise M +25,000 26.27 40,384 Form 4
2026-02-25 Huller KellyEVP, GC, Corporate Secretary Option exercise M +20,000 43.58 20,000 Form 4
2026-02-12 Huller KellyEVP, GC, Corporate Secretary Option exercise M +10,000 45.64 10,000 Form 4
2026-01-08 Kline KyleSenior Vice President, CFO Option exercise M +3,594 51.87 3,594 Form 4
2025-12-08 Paul David CDirector, Executive Chairman, 10% owner Option exercise M +34,375 25.52 60,417 Form 4
2025-12-01 Kline KyleSenior Vice President, CFO Option exercise M +3,646 53.14 3,646 Form 4
2025-12-01 Kline KyleSenior Vice President, CFO Option exercise M +5,000 56.43 8,646 Form 4
2025-12-01 Kline KyleSenior Vice President, CFO Option exercise M +5,000 64.44 13,646 Form 4
2025-12-01 Kline KyleSenior Vice President, CFO Option exercise M +4,896 63.68 18,542 Form 4
2025-11-25 Huller KellySVP, GC, Corporate Secretary Option exercise M +7,500 25.96 7,500 Form 4
2025-11-12 Davidar David DDirector Option exercise M +25,000 25.52 541,275 Form 4
2025-11-11 Zarrilli Stephen TDirector Option exercise M +25,000 44.14 25,000 Form 4
2025-01-10 Pfeil Keith WCOO, CFO Option exercise M +5,833 49.65 5,833 Form 4
2025-01-10 Pfeil Keith WCOO, CFO Option exercise M +8,334 53.27 14,167 Form 4
2025-01-02 Davidar David DDirector Gift G −6,100 – 510,175 Form 4
2024-12-02 Huller KellySVP, GC, Corporate Secretary Option exercise M +2,500 24.21 2,500 Form 4
2024-11-22 Lemaitre DanDirector Option exercise M +1,097 65.05 1,097 Form 4
2024-11-21 Scavilla Daniel TDirector, President, CEO Option exercise M +50,000 43.77 50,000 Form 4
2024-11-21 Scavilla Daniel TDirector, President, CEO Option exercise M +80,000 43.58 130,000 Form 4
2024-11-21 Lemaitre DanDirector Option exercise M +13,278 65.05 13,278 Form 4
2024-11-15 Paul David CDirector, Executive Chairman, 10% owner Option exercise M +26,042 24.10 26,042 Form 4
2024-11-06 Scavilla Daniel TDirector, President, CEO Option exercise M +30,000 26.27 30,000 Form 4
2024-11-06 Scavilla Daniel TDirector, President, CEO Option exercise M +30,000 43.77 60,000 Form 4
2024-11-06 Huller KellySVP, GC, Corporate Secretary Option exercise M +5,000 24.21 5,000 Form 4

How to read it

Buy, sale
Code P and S on the form: shares bought or sold in the market, at the market price. The other codes are mostly pay (a grant, an option exercised) or tax (shares the company withheld), and say little about what the insider thinks of the price.
Plan
A sale or purchase under a Rule 10b5-1 plan, set up in advance and running on its own schedule. Since April 2023 the form has a box for it. Much executive selling is planned and says more about diversifying than about the company.
Holds after
The shares the insider still held after the trade, in the form the trade was in (directly, or indirectly through a trust or a fund).
Value
Shares times the price the form reports, which is often an average over several fills on the day.

Read from the SEC's own quarterly data sets of Forms 3, 4 and 5, and from each day's filings since the last one. A correcting amendment replaces the lines it restates. Every row links to its filing. None of this is advice: insiders sell for many reasons, and buy for fewer.

Globus Medical's scores and multiples ›